Brooklyn Endocrine Diabetes - NY Kings, Brooklyn 11210

Brooklyn Endocrine Diabetes entered the industry of Endocrinologists in 1990 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Endocrinologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Endocrinologists. The business provides service to the B2C market.

To acquire more information, please contact Anil Saxena, Office Manager by calling (718) 951-6495 during business hours. You can also write to the business’ Single Location at 1700 Flatbush Avenue, Brooklyn, New York NY 11210. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Brooklyn Endocrine Diabetes
Representative: Anil Saxena, Office Manager
Place of Business: 1700 Flatbush Avenue, Brooklyn, NY 11210
Contact Number: (718) 951-6495
Type of Service: Endocrinologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1990
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Brooklyn Endocrine Diabetes is a company operating from Kings, New York providing professional Endocrinologists and relevant B2C variables. It was founded in 1990 and registered with the SIC code 8011 as Endocrinologists, and with the NAICS code 6211110 as Endocrinologists.

With a current employee count of 1 to 4, Brooklyn Endocrine Diabetes has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Anil Saxena, Office Manager at (718) 951-6495 for related queries, or to locate its Single Location using the coordinates 40.629302,-73.94412.

The Single Location can also be found at the street address 1700 Flatbush Avenue in Brooklyn, New York 11210 and can be engaged online through the company website at , the company Twitter , and Facebook page .